Arrowhead Pharmaceuticals vs United Therapeutics
Arrowhead Pharmaceuticals (ARWR) and United Therapeutics (UTHR) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $5.85B
- Last close
- $41.37
- 12 months
- +8.6%
- Market value
- $23.6B
- Last close
- $554.73
- 12 months
- +16.9%
At a glance
- The biggest part of United Therapeutics's revenue is Tyvaso DPI, 41% of the total in its last annual report.
- By market value, United Therapeutics ($23.6B) is about 4.0 times Arrowhead Pharmaceuticals ($5.8B).
- Over the last 12 months Arrowhead Pharmaceuticals's share price moved +8.6% and United Therapeutics's +16.9%; against the S&P 500 that is +2.9 points and +11.1 points.
- In their last fiscal years Arrowhead Pharmaceuticals kept -160.6% of revenue as net income and United Therapeutics 41.9%.
- In the last 90 days insiders reported 0 open-market purchases at Arrowhead Pharmaceuticals and 0 at United Therapeutics; members of Congress disclosed 0 trades in Arrowhead Pharmaceuticals and 0 in United Therapeutics.
- Next results: Arrowhead Pharmaceuticals Feb 3, 2027, United Therapeutics Feb 23, 2027.
How each one makes money: Arrowhead Pharmaceuticals revenue · United Therapeutics revenue
Share prices on one chart
Arrowhead Pharmaceuticals and United Therapeutics, and up to three more you add, drawn on the same scale so you can see which moved more.
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Every figure
| Arrowhead Pharmaceuticals ARWRNASDAQ · Biotechnology | United Therapeutics UTHRNASDAQ · Biotechnology | |
|---|---|---|
| Size and profitability | ||
| Market value | $5.85B | $23.6B |
| Revenue, last fiscal year | $451M | $3.18B |
| Net income, last fiscal year | −$724M | $1.33B |
| Net marginNet income as a share of revenue | -160.6% | 41.9% |
| Free cash flow | −$284M | |
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Common questions
How is Arrowhead Pharmaceuticals different from United Therapeutics?
Arrowhead Pharmaceuticals (ARWR) is in Biotechnology on NASDAQ, with $451M of revenue in its last fiscal year and a net margin of -160.6%. United Therapeutics (UTHR) is in Biotechnology on NASDAQ, with $3.18B of revenue in its last fiscal year and a net margin of 41.9%. The biggest part of United Therapeutics's revenue is Tyvaso DPI, 41% of the total in its last annual report. The table above sets their figures side by side; it compares filings and is not a view on either stock.
How do Arrowhead Pharmaceuticals and United Therapeutics compare in size?
United Therapeutics has the larger market value: Arrowhead Pharmaceuticals $5.85B and United Therapeutics $23.6B, at the last close.
Whose share price rose more over the last 12 months, ARWR or UTHR?
Over the last 12 months Arrowhead Pharmaceuticals moved +8.6% and United Therapeutics +16.9%. Past price moves say nothing about the future.
Which has had more insider buying, Arrowhead Pharmaceuticals or United Therapeutics?
Since 2006, United Therapeutics insiders reported 43 open-market purchases against 26 for Arrowhead Pharmaceuticals. These are counts of what was filed, not a view on either stock.
Do members of Congress trade ARWR or UTHR?
In the last 12 months, members of Congress disclosed 0 trades in Arrowhead Pharmaceuticals (ARWR) and 0 in United Therapeutics (UTHR).
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Arrowhead Pharmaceuticals pageUnited Therapeutics pageRare insider trades this weekAll comparisons
https://oqro.io/compare/arwr-vs-uthr

